We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Fungal Defensin Is Potent Antibiotic

By Biotechdaily staff writers
Posted on 09 Nov 2005
A potent peptide antibiotic of the defensin family has been isolated from a mushroom and shown to be as effective as vancomycin and penicillin in curing mice of experimentally induced peritonitis and pneumonia.

Investigators from the University of California, Los Angeles (USA), Georgetown University (Washington, DC, USA), and the biotechnology company Novozymes (Bagsvaerd, Denmark) collaborated on the isolation of the defensin plectasin from the saprophytic ascomycete Pseudoplectania nigrella and subsequently on its large-scale production using recombinant techniques.

They reported in the October 13, 2005, issue of Nature that the recombinant form of plectasin was especially active against Streptococcus pneumoniae, including strains resistant to conventional antibiotics. More...
They found that the structure of plectasin was remarkably similar to the defensins of spiders, scorpions, dragonflies, and ticks, which suggested that the defensins of insects, mollusks, and fungi arose from a common ancestral gene that probably existed over a billion years ago.

"Most antibiotics used by humans are produced by fungi and certain soil bacteria,” said contributing author Dr. Michael Zasloff, professor of pediatric surgery at Georgetown University Medical Center. "Using our existing tools of discovery, we have failed to uncover any new classes of antibiotics from these sources over the past decade. However, by utilizing a new genetic approach that allowed the team to discover plectasin, we now know that a whole class of antibiotics has been overlooked.”




Related Links:
University of California, Los Angeles
Georgetown University
Novozymes

New
Gold Member
Automatic Hematology Analyzer
CF9600
New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Urine Analyzer
respons® UDS100
New
Steam Sterilizer
Hi Vac II Line
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.